Mar 11 |
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
Mar 5 |
Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
|
Feb 26 |
12 $10 Stocks That Will Triple
|
Feb 26 |
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
|
Feb 24 |
Steven Cohen's Point72 Adds Caribou Biosciences Inc to Its Portfolio
|
Feb 12 |
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare
|
Feb 7 |
Caribou Biosciences (NASDAQ:CRBU) Is In A Good Position To Deliver On Growth Plans
|
Feb 1 |
Caribou Biosciences: Under The Radar With Catalysts Approaching
|
Jan 25 |
Biotech And Pharma Diversification Pays Off
|
Jan 15 |
3 Biotech Stocks You Can Buy and Hold for the Next Decade
|